A drug long-used to counter the negative effects of chemotherapy has won US Food and Drug Administration (FDA) approval for use in treating the nasty effects of exposure to radiation following a nuclear disaster. Known commercially as Neupogen, the drug has been shown to work by shielding the body's white blood cells to heighten a patient's chances of survival.
.. Continue Reading FDA ticks off first drug to treat radiation sickness after nuclear disastersSection: Medical
Tags: Related Articles:
- Toshiba unveils four-legged nuclear plant inspection robot
- ESA testing materials to shield astronauts from cosmic radiation
- Wallet-sized dosimeter would alert users to dangerous radiation levels
- New spectrometer developed for faster cleanup of nuclear-contaminated sites
- New radiation-resistant circuits could aid work in damaged nuclear power plants
- High-Access Survey Robot begins work at TEPCO nuclear plant
from Gizmag Emerging Technology Magazine http://ift.tt/1dsFDH9
No comments:
Post a Comment